2m 2m 2m 2m 2m 2m 2m
BIONXS GENE LAB (BGLC)
NASDAQ
$1.26-$0.01 (-1.10%)
Price as of Oct 02, 2026 7:30 PM EDT- $3.5MMarket Cap
- -75.99%1-Year Change
- Specialty ChemicalsIndustry
BIONXS GENE LAB (BGLC)
$1.26-$0.01 (-1.10%)
BGLC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.27 | ||
Change | +$0.07 (+5.83%) | ||
Open | $1.25 | ||
High | $1.28 | ||
Low | $1.25 | ||
Previous Close | $1.20 | ||
Volume | 2,950 | ||
30-Day Average Volume | 7,347 | ||
1-Week Change | -8.63% | ||
1-Month Change | -13.61% | ||
1-Year Change | -75.99% | ||
3-Year Change | -84.47% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 2.9M | ||
Total Assets | $8.7M | ||
Market Cap | $3.5M | ||
Enterprise Value | $2.3M | ||
Period: QTR TTM FY | |||
Revenue | $76,156.00 | ||
Net Income | -$286,451.00 | ||
Free Cash Flow | -$422,741.00 | ||
EBIT | -$286,451.00 | ||
EBITDA | -$258,386.00 | ||
Net Working Capital | $4.1M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 0 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/07/2025 | ||
Earnings & Revenue